SOFIA (Bulgaria), August 3 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Friday its sales revenue fell by an annual 6% in the first seven months of 2018.
Domestic sales revenue lost 5% year-on-year in the January-July period, while exports fell by 6%, the company said in a bourse filing.
In July alone, Sopharma's sales added 10% year-on-year as exports grew 14%, while domestic sales increased by 3%.
The company did not disclose information about the volume of its sales or amount of sales revenue.
As at 12:25 CEST on Friday, Sopharma shares traded 0.74% higher at 4.07 levs ($2.4/2.1 euro) on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)